 Home > Medical News > Latest Medical News > Innovent submits a listing application for new indications of Sintilizumab

Innovent submits a listing application for new indications of Sintilizumab

 Last Update: 2021-09-30
 Source: Internet
 Author: User

Tags

monoclonal antibodies wiki

car cell treatment

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Article source: Medical Rubik's Cube Info

Author: Sunshine

On September 22, the official website of CDE showed that Cinda BioSintilimab injection's new indications for listing application were accepted

Sintilimab (trade name Daboshu) is an innovative PD-1 inhibitor drug jointly developed by Innovent and Eli Lilly

At present, Sintilimab has been approved for four indications in China, namely: for the treatment of relapsed or refractory classic Hodgkin's lymphoma that has undergone at least second-line chemotherapy; combined with pemetrexed and platinum Chemotherapy is used for the first-line treatment of EGFR or ALK-negative advanced non-squamous NSCLC; combined with gemcitabine and platinum-based chemotherapy is suitable for the first-line treatment of non-resectable locally advanced or metastatic squamous NSCLC; combined with Dayton® (bevac Monoclonal antibody injection) is used for the first-line treatment of hepatocellular carcinoma

The marketing application is based on the international multi-center phase III clinical (ORIENT-15) data of combined cisplatin and paclitaxel/cisplatin and 5-fluorouracil for the first-line treatment of advanced or metastatic esophageal squamous cell carcinoma

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

jobs united states(236)

united states jobs(223)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

ups united states(221)

announcements today(81)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.